company

PHARMACOM AS

1391 VOLLEN

Return on Equity
95 %
Current Ratio
1,48
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue774 000
Net Income285 000
Total Assets602 000
Total Equity300 000
Income (NOK)2022
Revenue774 000
Expenditure395 000
Operating Profit379 000
Financial Income0
Financial Costs0
Financial Balance0
Earnings Before Tax379 000
Tax94 000
Net Income285 000
Balance (NOK)2022
Total Fixed Assets154 000
Total Current Assets448 000
Total Assets602 000
Total Retained Equity200 000
Total Equity300 000
Total Long-Term Debt1 000
Total Current Debt302 000
Total Equity and Debt602 000
Cash flow (NOK)2022
Sales Income774 000
Other Income0
Revenue774 000
Cost of Goods Sold0
Salary Costs19 000
Depreciation0
Impairment0
Expenditure395 000
Operating Profit379 000
Financial Income0
Financial Costs0
Financial Balance0
Dividends0
Net Income285 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures54 000
Total Tangible Assets54 000
Total Fiancial Fixed Assets100 000
Total Fixed Assets154 000
Stock0
Total Investments0
Cash, Bank448 000
Total Current Assets448 000
Total Assets602 000
Total Equity300 000
Short-Term Group Debt0
Total Long-Term Debt1 000
Creditors0
Unpaid Taxes145 000
Dividends0
Other Current Debt63 000
Total Current Debt302 000
Total Equity and Debt602 000
Financial indicators2022
Return on Equity95 %
Debt-to-Equity Ratio0
Operating Profit Margin48,97 %
Current Ratio1,48
Quick Ratio1,48
Equity Ratio0,5
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English